Publications by authors named "Matthew Hillebrenner"

Claim this Profile
A
Automated noninvasive blood pressure monitors: a Food and Drug Administration review perspective.
Bradley Quinn, Shawn Forrest, Matthew Hillebrenner, Bram Zuckerman

Blood Press Monit· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA in the 21st Century: Focus on Tobacco Policies and Heart Failure Prevention.
Mona Fiuzat, Tamar S Nordenberg, Mitchell Zeller, Matthew G Hillebrenner, Norman Stockbridge

JACC Heart Fail· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug Development.
Norman Stockbridge, Kristen Miller, Shashi Amur, Matthew Hillebrenner, Bram Zuckerman

JACC Heart Fail· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure Devices.
Matthew Hillebrenner, Bram Zuckerman, Mona Fiuzat, Norman Stockbridge, Robert Califf

JACC Heart Fail· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food and Drug Administration commentary on "a new paradigm for obtaining marketing approval for pediatric-sized prosthetic heart valves".
Fernando Aguel, Steven B Kurtzman, Sonna Patel-Raman, Matthew Hillebrenner, Bram D Zuckerman

J Thorac Cardiovasc Surg· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VARC consensus report: the FDA perspective.
Matthew G Hillebrenner, Julie A Swain, Bram Zuckerman

J Am Coll Cardiol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VARC consensus report: the FDA perspective.
Matthew G Hillebrenner, Julie A Swain, Bram Zuckerman

Eur Heart J· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA's perspectives on cardiovascular devices.
Eric A Chen, Sonna M Patel-Raman, Kathryn O'Callaghan, Matthew G Hillebrenner

J Cardiovasc Transl Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic inquiry into decrease in probability of defibrillation success with increase in complexity of preshock reentrant activity.
Matthew G Hillebrenner, James C Eason, Natalia A Trayanova

Am J Physiol Heart Circ Physiol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postshock arrhythmogenesis in a slice of the canine heart.
Matthew G Hillebrenner, James C Eason, Craig A Campbell, Natalia A Trayanova

J Cardiovasc Electrophysiol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis